GLP-1s and Fertility: When to Stop Before Trying to Conceive

Yes. GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are not approved for use during pregnancy, and manufacturers recommend stopping them before you conceive. A GLP-1 receptor agonist is a medication that mimics a gut hormone to lower appetite and blood sugar. Animal studies have shown possible harm to the developing fetus, and there is not yet enough human safety data to consider them safe in pregnancy. Because these are once-weekly drugs, they stay in your body for weeks after your last dose. Semaglutide has a half-life of about 7 days and tirzepatide about 5 days, meaning it takes roughly 5 to 7 weeks for the drug to clear to very low levels. A narrative review in *Annals of Medicine and Surgery* (2025) notes that discontinuing after at least 5 half-lives — about 35 days for semaglutide — minimizes fetal exposure, though many clinicians use a more conservative 4- to 6-week or 2-month buffer to be safe.

The widely accepted guidance is to stop your GLP-1 at least 2 months before you begin trying to conceive. This is a cushion on top of the pharmacology. The drug itself clears in roughly 5 to 7 weeks, but a two-month gap gives your body time to fully wash out and lets your cycle settle before conception. Different drugs clear at different rates: liraglutide (Saxenda), a daily GLP-1, needs only about 3 days, while the once-weekly agents need weeks. If you are in a hurry to conceive, talk with your doctor about which medication and timeline fit your situation. This washout applies to fertility treatment too — most reproductive endocrinologists want patients off all GLP-1s well before ovarian stimulation or embryo transfer during IVF. Understanding [how GLP-1 medications work](/blog/how-glp-1-medications-work-incretin-mechanism-explained) helps explain why the clearance timeline matters so much.

"Ozempic babies" is the nickname for unplanned pregnancies that occur in people on GLP-1 medications, and they happen for two real biological reasons. First, weight loss and improved insulin sensitivity can restore ovulation in people who weren't ovulating regularly — especially those with PCOS (polycystic ovary syndrome, a hormonal condition that disrupts ovulation). If you assumed you couldn't easily get pregnant, returning fertility can catch you off guard. Second, and specific to tirzepatide, the drug can slow stomach emptying enough to reduce the absorption of oral contraceptives (birth control pills). The Mounjaro and Zepbound labels advise using a backup barrier method (like condoms) or switching to a non-oral contraceptive for 4 weeks after starting the drug and for 4 weeks after each dose increase. Semaglutide does not carry this specific warning. If avoiding pregnancy matters to you right now, don't rely on the pill alone while on tirzepatide.

For many people, yes — indirectly. Excess weight and insulin resistance are common drivers of infertility, particularly in PCOS, which affects roughly 1 in 10 people of reproductive age. By lowering weight, reducing insulin resistance, and often restoring regular menstrual cycles, GLP-1s can improve the odds of conceiving. The key is the handoff: you want the metabolic benefits, then a clean transition off the drug before you actually try. This is different from the medication being safe *during* pregnancy — it is not. Think of GLP-1s as preparing the ground, not as something you continue once you're trying. Hormone shifts on these drugs can also be noticeable; our guide on [how hormones change your medication response](/blog/glp-1-and-estrogen-how-hormones-change-medication-response) covers the estrogen connection in more depth.

If you discover you're pregnant while taking a GLP-1, stop the medication and contact your doctor promptly — do not wait for your next appointment. Current guidance is to discontinue immediately upon a confirmed pregnancy. Try not to panic: the existing human data, while limited, has not shown a clear pattern of birth defects, and many people have had healthy pregnancies after early exposure. Your provider will help you monitor the pregnancy and plan nutrition, since appetite and eating patterns often shift once you're off the drug. Keep taking or start a prenatal vitamin with folic acid, and focus on protein and hydration as your appetite returns. If you were managing side effects like [nausea on your GLP-1](/blog/glp1-nausea-why-it-happens-and-how-to-stop-it), note that pregnancy nausea can feel similar but needs a different approach.

The practical playbook is: talk to your doctor early, set a target date to stop the medication that's at least 2 months before you'll try, and build sustainable habits during that window so you don't rebound sharply once you're off. Some people work with their provider on a gentle taper rather than an abrupt stop, and lean into protein, strength training, and fiber to protect the progress they've made. Track more than the scale — energy, cycle regularity, and how your clothes fit. If cost is part of your planning (fertility care is expensive), our [GLP-1 savings guide](/blog/glp1-savings-cards-2026-complete-guide) can help you budget the months you'll be on and off the drug. Above all, make this a shared decision with your healthcare team, ideally including whoever will manage your pregnancy.